WuXi AppTec
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · China · 10K+ Employees
View Company Info for Free
Overview
Headquarters
288 Free Trade Zone, Shanghai, Shanghai,...Phone Number
+86 2150461111Website
www.wuxiapptec.comRevenue
$7.1 BillionStock Symbol
WUXAYIndustry
ZI Rank: 3
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
3
4
1
2
2
3
About WuXi AppTec
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Others. It offers contract research, development, and manufacturing organization services for new drug development from discovery to commercial covering various categories for various synthetic molecular modalities, including small molecules, oligonucleotides, peptides, and complex conjugates; and biology services and solutions that support stand-alone and integrated projects from target discovery to candidate selection and into the clinic.Explore more
WuXi AppTec Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is WuXi AppTec your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if WuXi AppTec is spiking on competitors!
WuXi AppTec, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at WuXi AppTec
Check if WuXi AppTec has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on WuXi AppTec recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if WuXi AppTec had a recent Job posting/layoffs
Funding: Get notified immidiatlly once WuXi AppTec has new funding data
Product Launch: Get notified when WuXi AppTec launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
WuXi AppTec is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
WuXi AppTec is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about WuXi AppTec.
WuXi AppTec financials insights
Gather financial insights about WuXi AppTec, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2007
Stock Offering
$184.6M
2016
Debt
$1.5B
2024
Other Financing Round
$500M
WuXi AppTec Tech Stack
A closer look at the technologies used by WuXi AppTec
See more technologies
Most Recent Scoops
Person-Based
Lawsuits, Legal Affairs
Open Position
Event
Product Marketing, Events, Engineering, Contingent Workforce, Sales, Outsourcing, Bioengineering, Chemical Engineering, Field /Outside Sales, Field Marketing
Event
Product Marketing, Events, Contingent Workforce, Sales, Outsourcing, Logistics / Supply Chain, Pharmaceuticals, Field /Outside Sales, Operations
Person-Based
Medical Research, Pharmaceuticals
WuXi AppTec News & Media
WuXi AppTec's Integrated CRDMO Model Shortens Discovery-to-IND Timelines for Biotechnology Partners
SAN DIEGO, CA, UNITED STATES, August 4, 2026 /EINPresswire.com/ -- Key Takeaways Investigational New Drug (IND) submission requires coordinated decisions across biology, DMPK, bioanalysis, and chemistry, manufacturing, and controls (CMC). WuXi …WuXi AppTec Delivers Strong H1 2026 Results and Raises Full-Year Guidance[1], Driven by Greater Success of Multiple Customers' Products and CRDMO Model
SHANGHAI, Aug. 3, 2026 /PRNewswire/ -- WuXi AppTec (stock code: 603259.SH / 2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today announced financial results for the first half ending June 30, 2026 ("Reporting Period"). The Company raised its full-year guidance, citing strong performance across revenue, profit, and cash flow driven by the greater success of multiple customers' products and its unique integrated CRDMO platform. FinWuXi AppTec Named Constituent of the FTSE4Good Index Series for Fourth Consecutive Year
SHANGHAI, July 21, 2026 /PRNewswire/ -- WuXi AppTec, a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), announced it has been named in the FTSE4Good Index Series for the fourth consecutive year, reflecting the Company's sustained...The Role of CROs and CDMOs in Supporting Global Drug Development
SAN DIEGO, CA, UNITED STATES, July 8, 2026 /EINPresswire.com/ -- A CRO/CDMO that can support global drug development should combine modality-specific technical expertise, global regulatory experience, scalable manufacturing, mature quality systems, …
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding WuXi AppTec
Sign Up For FreeTo access detailed company insights
WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in the People's Republic of China, the United States, Europe, and internationally. The company operates in six segments: WuXi Chemistry, WuXi Testing, WuXi... Read More
